Literature DB >> 1967677

Self-management of adrenal insufficiency by rectal hydrocortisone.

P G Newrick1, G Braatvedt, J Hancock, R J Corrall.   

Abstract

An alternative to intramuscular hydrocortisone self-injection was evaluated in healthy controls and in patients with adrenal insufficiency. Plasma cortisol concentrations were assayed after administration of 200 mg hydrocortisone by intramuscular injection (10 healthy subjects) or after insertion of an identical dose by rectal suppository (12 healthy subjects, 3 patients with adrenal failure). Plasma cortisol concentrations peaked at 1 hour (about 4000 nmol/l) following intramuscular injection and declined thereafter. After rectal administration, levels peaked at between 1 and 2 hours and persisted for 8 or more hours. Similar levels were achieved at 4 hours (about 1000 nmol/l) by both methods of administration. Self-treatment by rectal suppository may be useful in the prevention of Addisonian crises.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967677     DOI: 10.1016/0140-6736(90)90289-h

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Patients' self administration of hydrocortisone.

Authors:  G D Braatvedt; P G Newrick; R J Corrall
Journal:  BMJ       Date:  1990-12-08

2.  Rectal hydrocortisone during stress in patients with adrenal insufficiency.

Authors:  M De Vroede; R Beukering; M Spit; M Jansen
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

3.  Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes.

Authors:  David R Parker; Geoffrey D Braatvedt; Alexandra Bargiota; Paul G Newrick; Stephen Brown; Gregory Gamble; Roger J M Corrall
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

Review 4.  Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.

Authors:  Ashley Grossman; Gudmundur Johannsson; Marcus Quinkler; Pierre Zelissen
Journal:  Eur J Endocrinol       Date:  2013-10-21       Impact factor: 6.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.